Company: MDCXW
Filing Date: 2025-08-11
Form Type: 10-Q
Source: 0001062993-25-014058
Chunk: 103

Company: Medicus Pharma Ltd.
Filing Date: 2025-08-11
Form: 10-Q
Item: Part I, Item 8
Chunk 103
---
 6,016,088  3,553,834  2,462,254  11,142,362  5,261,192  5,881,170 Loss from operations (6,016,088) (3,553,834) (2,462,254) (11,142,362) (5,261,192) (5,881,170)Other income (expense):                  Interest income, net 40,004  (79,025) 119,029  63,870  (79,025) 142,895 Change in fair value of Debentures (200,000) -  (200,000) (200,000) -  (200,000)Total other income (expense) (159,996) (79,025) (80,971) (136,130) (79,025) (57,105)Net loss and comprehensive loss (6,176,084) (3,632,859) (2,543,225) (11,278,492) (5,340,217) (5,938,275)Net loss per common share (basic and diluted) (0.43) (0.44)    (0.81) (0.66)   

General and administrative

  Three months ended June 30,     Six months ended June 30,      2025  2024     2025  2024      $  $  Change   $  $  Change Professional fees 1,944,559  621,040  1,323,519  3,305,037  1,059,342  2,245,695 Consulting fees 383,270  483,380  (100,110) 668,216  939,194  (270,978)Salaries, benefits, and compensation 908,599  303,390  605,209  1,378,393  540,359  838,034 General office, insurance and administrative expenditures 724,800  716,422  8,378  1,264,698